895, Mowry Avenue
Founded in 2007, Plaxgen is a biodiagnostics company with a unique diagnostic platform to personalized medicine. We are focused on developing innovative technology for clinical diagnostics and the discovery of effective therapeutics to treat a broad spectrum of plaque-related diseases, including Alzheimer’s disease (AD) and atherosclerosis. Plaxgen’s proprietary Plaque Array platform was developed to detect and characterize serum-derived particles containing cholesterol or amyloid beta protein (abeta), tau and a-synuclein.
Founder and CEO: Shanmugavel Madasamy